Company Badge
USPTO Data Jan 1 1976 - Oct 6 2026
4 Patents
#1,006 in San Diego, CA
#14,041 in California
#60,597 in US
Kalyra Pharmaceuticals, Inc.
Forward Citations = 42
8 inventors:
San Diego, CA, United States of America
Kalyra Pharmaceuticals, Inc.
% Expired Patents = 50.0
CIPO Patents = 7
Forward Citations = 42
Loading Chart...
Loading Chart...
8 inventors (with patents filed for the assignee):
Kevin Duane Bunker (4 out of 46 patents)
Joseph Robert Pinchman (26 patents)
Peter Qinhua Huang (37 patents)
4. Chad Daniel Hopkins (16 patents)
5. Deborah Helen Slee (12 patents)
6. Mark Charles Grier (2 patents)
7. Mehmet Kahraman (34 patents)
8. Chuangxing Guo (0 patent)
4 patents:
Company Overview
Kalyra Pharmaceuticals, Inc. is a leading biopharmaceutical company dedicated to developing innovative therapies for various diseases. With a focus on research and development, Kalyra is committed to improving patient outcomes and quality of life. Their portfolio includes novel treatments for cancer, autoimmune disorders, and infectious diseases, with a mission to bring breakthrough medicines to market.
Profile summary synthesized from public USPTO records and patent filings.
IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Kalyra Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/kalyra-pharmaceuticals
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
7 patents (CIPO):
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]